You can buy or sell CMPI and other stocks, options, and ETFs commission-free!
Checkmate Pharmaceuticals, Inc. Common Stock, also called Checkmate Pharmaceuticals, is a clinical-stage biotechnology company. Read More It engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. It specializes in the field of CpG oligonucleotides. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. The listed name for CMPI is Checkmate Pharmaceuticals, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 16, Pre-Market